Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity.
Saved in:
| Title: | Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity. |
|---|---|
| Authors: | Lee W; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Synn CB; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee HK; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Park S; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Jung DS; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Choi Y; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Kim JH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Byeon Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Joo Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee EJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Yun MR; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Heo SG; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Yang W; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Jung JE; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim EK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Park J; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Park JD; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea., Lee DJ; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea., Kim HW; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea., Lim SM; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Hong MH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Ahn BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Center for Lung Cancer, National Cancer Center, Goyang-si, South Korea., Lee JB; Division of Hemato-oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea., Pyo KH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Mar 09; Vol. 12, pp. 821391. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2022.821391 |
